BDBM355702 1-(2-{(1R,3S,5R)-3-[(1R,2S)-2-(2- Chloro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo- ethyl)-1H-pyrazolo[3,4-c]pyridine- 3-carboxylic acid amide::US9815819, 67

SMILES NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2Cl)c2cnccc12

InChI Key InChIKey=SRUVQNXKBMRRSH-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 355702   

TargetComplement factor D(Human)
Novartis

US Patent
LigandPNGBDBM355702(US9815819, 67 | 1-(2-{(1R,3S,5R)-3-[(1R,2S)-2-(2- ...)
Affinity DataIC50: 35nMAssay Description:Method 1: Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent